PAMCX
Price
$96.01
Change
+$0.40 (+0.42%)
Updated
Jul 3 closing price
Net Assets
28B
VSCRX
Price
$57.62
Change
+$0.27 (+0.47%)
Updated
Jul 3 closing price
Net Assets
2.18B
Interact to see
Advertisement

PAMCX vs VSCRX

Header iconPAMCX vs VSCRX Comparison
Open Charts PAMCX vs VSCRXBanner chart's image
T. Rowe Price Mid-Cap Growth Adv
Price$96.01
Change+$0.40 (+0.42%)
VolumeN/A
Net Assets28B
Virtus KAR Small-Cap Core R6
Price$57.62
Change+$0.27 (+0.47%)
VolumeN/A
Net Assets2.18B
PAMCX vs VSCRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PAMCX vs. VSCRX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAMCX is a StrongBuy and VSCRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 28B vs. VSCRX (2.18B). VSCRX pays higher dividends than PAMCX: VSCRX (0.34) vs PAMCX (0.00). PAMCX was incepted earlier than VSCRX: PAMCX (25 years) vs VSCRX (11 years). PAMCX (1.01) is less costly to investors than VSCRX (0.92). PAMCX is a more actively managed with annual turnover of: 22.60 vs. VSCRX (5.00). PAMCX has a lower initial minimum investment than VSCRX: PAMCX (2500) vs VSCRX (2500000). VSCRX annual gain was more profitable for investors over the last year : 7.92 vs. PAMCX (-2.05). VSCRX return over 5 years is better than : 47.65 vs. PAMCX (5.54).
PAMCXVSCRXPAMCX / VSCRX
Total Expense Ratio1.010.92110%
Annual Report Gross Expense Ratio1.010.92110%
Fund Existence25 years11 years-
Gain YTD2.1820.734297%
Front LoadN/AN/A-
Min. Initial Investment250025000000%
Min. Initial Investment IRAN/AN/A-
Net Assets28B2.18B1,282%
Annual Yield % from dividends0.000.34-
Returns for 1 year-2.057.92-26%
Returns for 3 years13.7038.8035%
Returns for 5 years5.5447.6512%
Returns for 10 years20.74138.0015%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GANX1.690.06
+3.36%
Gain Therapeutics
AVDL8.930.12
+1.36%
Avadel Pharmaceuticals plc
ENSG150.181.27
+0.86%
Ensign Group (The)
STEM7.52N/A
N/A
Stem Inc
PNFPP24.20-0.05
-0.21%
Pinnacle Financial Partners